Concept illustration of precision targeting in macular research
December 23, 2025

Beyond the Vessels

After years of firing blanks at MacTel, researchers may have finally hit their target…by aiming at the neurons instead of…

APVRS 25 Article Thumb Day 2 1
December 13, 2025

When Retina Meets Glaucoma at APVRS 2025

When glaucoma complicates the retina, the rulebook gets rewritten. Here’s how the experts adapt.  On Day 2 of the 18th…

popular posts
speaker at the podium with thumbs up and thumbs down
December 13, 2025

Retina on the Ropes: Tackling the Toughest Debates in Medical Retina at APVRS 2025

latest posts
Euretina Session 2
September 5, 2025

EURETINA 2025: What’s Next in the Neovascular AMD Playbook

PIEE 35 COVER HORIZONTAL 01 (1)
July 31, 2025

Copycats or Game-changers?

Aflib_8_mg_6_months_intervals_in_EU_ _thumbnail
June 30, 2025

Eylea 8 mg Approved in EU for 6-Month Dosing in nAMD and DME

Thumbnail Article AMD Barometer Piece (1)
June 11, 2025

Adherence in 2025: How Close Are We to Finally Solving the Retinal Treatment Burden?

SUSVIMO implant
May 23, 2025

FDA Approves Roche’s Susvimo for Diabetic Retinopathy

FDA Rejects Regeneron’s Bid to Extend EYLEA HD Dosing Beyond 16 Weeks
April 22, 2025

FDA Rejects Regeneron’s sBLA to Extend EYLEA HD Dosing Interval

z4889203089827_b383d19bbac9759a10fd0883c30c5733
November 17, 2023

Geeking Out on Gels and Nanos: Move over, anti-VEGF and lasers! There’s a new cool posterior segment tech in town!

COVER ART TOC
November 17, 2023

A REVOLUTION in Retinal Therapies: From anti-VEGF to TKIs and gene therapy, cutting-edge innovations are changing the landscape of medical retina

Discover our fascinating content at issuu

explore